Optimization of seizure prevention by cannabidiol (CBD)
Cannabidiol (CBD) is one of the most prominent non-psychotropic cannabinoids with known therapeutic potentials. Based on its anti-seizure efficacy, the first cannabis derived pharmaceutical grade CBD-based medication was approved in the USA in 2018 for the treatment of seizures in patients 2 years a...
Salvato in:
| Autori principali: | , , , , , , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
De Gruyter
2025-03-01
|
| Serie: | Translational Neuroscience |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1515/tnsci-2022-0362 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
